When protection turns into burden: Policyholders cancelling health insurance plans as premiums spike
This is likely to aggravate the existing challenges in the public health system.
Trial of new Covid treatment yields encouraging results, study shows
The new treatment involves a single dose of pegylated lambda-interferon, a synthetic version of a naturally occurring protein that infected cells secrete to defend against viral infection.
Agong undergoing medical procedure, follow-up care at IJN
Sultan Abdullah Sultan Ahmad Shah was scheduled to undergo the procedure in mid-September, but it was postponed due to his visit to the UK for the funeral of Queen Elizabeth II.
EU agency clears arthritis drug for severe Covid cases
Previously approved for arthritis in adults and children, tocilizumab works by suppressing a dangerous 'cytokine storm' overreaction of the immune system to the coronavirus.
Sarawak’s main hospital struggles with Covid wave as private centres cease virus treatment
Sarawak General Hospital has seen a dramatic increase of Covid-19 patients in its ICU ward.
Court allows Zahid’s bid for return of passport to seek treatment in Germany
His lawyer says the temporary release of the passport will not affect the Umno president's next trial date.
AstraZeneca hails trial results for Covid treatment
It is hoped that the drug could be used alongside vaccines for those who need more protection, affording up to 12 months of defence.
WHO mass-testing three potential Covid-19 treatments
Artesunate, imatinib and infliximab will be tested on thousands of volunteer patients in more than 600 hospitals in 52 countries.
Why ivermectin should not be used to treat or prevent Covid-19
Taking large doses of this drug is dangerous and can cause serious harm.
Health experts pan calls by PH reps for ivermectin to treat Covid-19
They recommend waiting for authentic information obtained through clinical studies on the matter.
Arthritis drug shows promise against severe Covid, study says
After 28 days, 18.1% of the group receiving the tofacitinib progressed to respiratory failure or death, compared to 29% in the placebo group – a statistically significant relative risk reduction of 63%.
AstraZeneca hits snag in Covid drug development
The drug, which has been undergoing final clinical trials to assess its safety and efficacy, failed its main goal to treat Covid-19 symptoms in exposed patients.
